TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Tumor progression locus 2 (TPL2) is a key signaling molecule in inflammatory responses.
• Microglia, the brain's immune cells, play a critical role in neuroinflammation and neurodegeneration.
• TPL2's role in microglial function and its impact on neurodegenerative diseases are not fully understood.

Purpose of the Study:

• To investigate the role of TPL2 kinase activity in microglial function and neuroinflammation.
• To determine if TPL2 inhibition can ameliorate pathology in a tauopathy model.
• To explore TPL2 as a potential therapeutic target for neurodegenerative conditions.

Main Methods:

• In vitro studies on microglia-mediated neuron death.
• In vivo studies using acute neuroinflammation models.
• Analysis of a tauopathy mouse model with TPL2 inhibition.
• Single-cell RNA sequencing to assess immune cell populations.

Main Results:

• TPL2 kinase activity modulates microglial cytokine release and neuron death in vitro.
• TPL2 regulates microglia activation states and cytokine levels during acute neuroinflammation.
• Loss of TPL2 kinase activity reduced neuroinflammation, synapse loss, and behavioral deficits in a tauopathy model.
• Protection was linked to reduced activated microglia and peripheral immune cell infiltration.

Conclusions:

• TPL2 kinase activity promotes detrimental microglial activation, including cytokine release, iNOS induction, and immune cell infiltration.
• Inhibiting TPL2 kinase activity demonstrates therapeutic potential in preclinical models of neurodegeneration.
• Targeting TPL2 offers a promising strategy for managing neuroinflammation in neurodegenerative diseases.